American Century Companies’s Bioverativ Inc. Common Stock BIVV Stock Holding History

American Century Companies’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,220	Closed	-$551K	–	1398
2017 Q4	$551K	Sell	10,220 -833,802	-99%	-$45.6M	﹤0.01%	1183
2017 Q3	$48.2M	Buy	844,022 +57,862	+7%	+$3.39M	0.05%	378
2017 Q2	$47.3M	Buy	+786,160	New	+$44.8M	0.05%	379

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

American Century Companies's BIVV Position: Q1 2018 in Review

American Century Companies sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 10,220 shares — an estimated $551K sold.

American Century Companies first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $48.2M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

American Century Companies reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
American Century Companies sold 10,220 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $551K.
American Century Companies first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
American Century Companies's Bioverativ Inc. Common Stock position peaked at $48.2M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on American Century Companies's 13F filing for Q1 2018, filed 3 May 2018.